Skip to main content
. Author manuscript; available in PMC: 2016 Jun 2.
Published in final edited form as: Nature. 2015 Apr 8;522(7557):487–491. doi: 10.1038/nature14411

Extended Data Table 4.

Pharmakokinetics of 3BNC117 based on a 56-day period post infusion. Estimation of PK parameters retrieved from study participants (ID) up to 8 weeks post 3BNC117 infusion. 3BNC117 was administered at 1, 3, 10, and 30 mg/kg in uninfected (Negative) and HIV-1-infected (Positive) individuals. 3BNC117 serum concentrations were determined by ELISA or TZM.bl assay (see Methods). PK-parameters were obtained by performing a non-compartmental analysis (NCA) using WinNonlin 6.3. T1/2 was estimated using values between Lambda upper/lower. n.d., PK parameters were not determined because of insufficient data or an extrapolated AUC_inf that exceeded 25%. Values in red indicate extrapolated AUC_inf >10%.*, Days post infusion of 3BNC117.

ID HIV-1/ART 3BNC117
(mg/kg)
Method Cmax
(μg/ml)
adjusted
R-squared
Estimated
T1/2 (days)
Lambda
(lower)*
Lambda
(upper)*
AUC
(INF_pred)
Tlast* Clast
(μg/ml)
AUC_%
Extrap_pred
1A1 Negative 1 ELISA 27.4 n.d. n.d. n.d. n.d.
TZM.bl 27.4 0.936 21.32 14 42 184.0 42 1.2 19.2
1A2 Negative 1 ELISA 18.8 n.d. n.d. n.d. n.d.
TZM.bl 27.8 0.893 12.89 7 42 181.7 42 1.0 9.0
1A3 Negative 1 ELISA 11.2 n.d. n.d. n.d. n.d.
TZM.bl 23.5 0.976 10.38 4 28 138.0 28 1.3 14.0
2A1 Positive/Off 1 ELISA 15.7 n.d. n.d. n.d. n.d.
2A3 Positive/Off 1 ELISA 22.7 n.d. n.d. n.d. n.d.
2A4 Positive/Off 1 ELISA 33.8 n.d. n.d. n.d. n.d.
TZM.bl 15.6 n.d. n.d. n.d. n.d.

1B1 Negative 3 ELISA 89.9 0.985 19.64 7 56 685.2 56 3.1 12.1
TZM.bl 70.9 0.881 24.30 7 56 483.7 56 2.7 17.9
1B2 Negative 3 ELISA 90.1 0.878 12.91 7 42 523.5 42 2.2 8.8
TZM.bl 116.0 0.936 10.04 7 42 481.2 42 1.4 4.6
1B3 Negative 3 ELISA 243.4 0.954 21.54 14 56 1017.3 56 4.2 12.1
TZM.bl 74.5 0.954 21.70 7 56 706.6 56 3.9 15.6
2B1 Positive/Off 3 ELISA 90.8 0.942 9.60 4 21 219.4 21 2.8 19.2
TZM.bl 57.4 0.994 10.28 7 28 245.9 28 1.9 12.1
2B2 Positive/On 3 ELISA 97.6 0.928 8.74 7 21 200.7 21 2.5 16.5
2B3 Positive/Off 3 ELISA 60.0 0.981 9.08 4 21 251.2 21 3.5 17.0
TZM.bl 32.6 0.994 9.19 4 28 129.8 28 1.0 10.1

1C1 Negative 10 ELISA 347.8 0.942 16.33 7 56 1667.9 56 5.9 7.5
TZM.bl 281.8 0.964 15.79 7 56 1598.9 56 5.6 7.3
1C3 Negative 10 ELISA 308.9 0.860 29.01 7 56 2529.4 56 15.8 23.5
TZM.bl 244.7 0.700 26.59 14 56 2228.5 56 13.1 19.3
1C4 Negative 10 ELISA 180.6 0.835 10.73 7 42 859.1 42 4.0 5.5
TZM.bl 230.7 0.990 10.56 14 56 1022.0 56 1.4 2.2
2C2 Positive/On 10 ELISA 326.8 0.866 10.87 7 42 904.5 42 2.7 5.6
2C4 Positive/Off 10 ELISA 178.2 0.944 6.92 4 28 550.2 28 2.8 5.1
TZM.bl 193.0 0.979 6.14 4 28 417.9 28 1.8 3.4
2C5 Positive/Off 10 ELISA 201.1 0.997 6.60 7 28 592.6 28 2.6 4.1
TZM.bl 174.4 0.994 6.50 7 28 431.2 28 1.8 3.7

1E2 Negative 30 ELISA 360.8 0.930 14.48 7 56 4259.4 56 13.6 5.9
TZM.bl 1166.3 0.978 16.19 14 56 5901.2 56 16.1 6.2
1E3 Negative 30 ELISA 361.8 0.990 16.26 7 56 3177.5 56 11.7 8.2
TZM.bl 606.2 0.989 17.85 7 56 3422.2 56 12.3 9.3
1E5 Negative 30 ELISA 765.0 0.992 14.15 4 56 5874.2 56 16.3 5.7
TZM.bl 939.6 0.959 15.22 14 56 6424.5 56 19.1 6.1
2C1 Positive/Off 30 ELISA 410.2 0.991 5.80 7 28 1707.8 28 5.1 2.6
TZM.bl 717.4 0.993 5.99 7 42 2186.4 42 1.6 0.6
2D1 Positive/Off 30 ELISA 976.4 0.996 6.86 7 42 2494.9 42 3.4 1.3
TZM.bl 849.3 0.990 8.83 7 56 1825.5 56 1.1 0.8
2D3 Positive/Off 30 ELISA 571.0 0.962 13.39 7 56 3616.5 56 9.9 4.8
TZM.bl 953.7 0.993 11.23 7 42 4346.2 42 16.0 6.0
2E1 Positive/Off 30 ELISA 712.4 0.970 11.14 14 56 3028.5 56 4.6 2.3
2E2 Positive/Off 30 ELISA 789.4 0.920 11.14 7 56 3596.1 56 6.7 2.4
2E3 Positive/Off 30 ELISA 559.6 0.821 8.54 7 28 2495.6 28 13.7 8.4